Dentists in Mt View, CA Accepting Medicare
2 Dentists found. Showing 1 - 2
 Lorin George Maser, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 505 South Drive, Suite 3, Mt View, CA 94040 Phone: 650-964-8484 Fax: 650-964-8484 |
Dr. Bert D Rouleau, DMD MS Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1174 Castro St, # 120, Mt View, CA 94040 Phone: 650-964-6400 Fax: 650-964-0797 |
News Archive
FDA's PDAC supports use of Brintellix for treating cognitive dysfunction in adults with MDD
Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the U.S. Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee voted 8 to 2 that the companies presented substantial evidence to support the effectiveness of Brintellix (vortioxetine) for treating certain aspects of cognitive dysfunction in adults with Major Depressive Disorder (MDD).
SFDA approves China Medical Technologies' colorectal cancer assay
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that China's State Food and Drug Administration has approved the Company's real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog assay as a companion diagnostic test for the use of a targeted drug for the treatment of colorectal cancer patients.
Eppendorf's new Mastercycler® nexus X2 provides a multi-block solution for simultaneous PCR runs
Eppendorf has launched the latest offering in its range of molecular biology instruments. The new Mastercycler nexus X2 is ideal for researchers looking to carry out two PCR reactions simultaneously, without any compromise on the number of samples. The instrument comprises of two asymmetric blocks, consisting of 64 and 32 wells, which can be programmed and run completely independently, enabling two separate PCR protocols to be run in parallel.
Human testes respond differently to endocrine disrupting chemicals
Human and rat testes respond differently to endocrine disrupting chemicals such as BPA in two thirds of all cases, according to a recent review. As human safety levels are extrapolated from rodent data, the study could lead to a re-evaluation of the acceptable daily intake for many endocrine disruptors.
› Verified 6 days ago